SecondRead — Confidence Auditor for Clinical AI
A clinical decision-support layer that wraps any AI diagnostic or triage tool and warns physicians (and patients) when the underlying model is confidently wrong, forcing a second opinion on high-stakes cases.
Primary care physicians and small clinic teams using AI scribes, symptom checkers, or diagnostic assistants
- Confidence-band overlay on AI outputs that flags when agreement is high but the underlying literature shows accuracy has collapsed
- Mandatory second-opinion trigger for high-stakes specialties (oncology, cardiac, pediatric) with one-click referral to a human reviewer
- Audit log of every AI-assisted decision with confidence and outcome data, exportable for malpractice defense
- Patient-facing plain-language summary explaining what the AI said, how confident it was, and what the human doctor did differently
New audit research finds frontier LLMs are confidently wrong 48% of the time on cases where they agree with themselves, and clinicians are already using these tools in production without any calibration layer.
Strong primary-care AI scribe adoption: Canada Health Infoway funding 10,000 PCP one-year licenses (June 2025) and Ontario MD pilots report 3-4 hrs/week saved, with trust calibration flagged as a top adoption barrier in multiple 2024-25 clinical AI papers.AI Scribes in Canadian Health Care: Easing Documentation Burden ↗Enhancing Clinician Trust in AI Diagnostics: A Dynamic Framework ↗
No dominant 'confidence auditor' for clinical AI, but adjacent space is active: arXiv 2505.23075 'Consensus Mechanism' ensemble framework, npj Digital Medicine CLIX-M checklist, and generalist hallucination-detection vendors (Suprmind) are converging on the same gap.[2505.23075] Second Opinion Matters: Towards Adaptive Clinical AI via Consensus ↗Leading Companies for AI Hallucination Detection ↗
Clinical B2B SaaS is established and the $150B 'hallucination problem' framing creates urgency, but target buyers are small primary-care clinics with thin margins, and no public pricing benchmarks for a confidence-wrapper layer were found; willingness to pay is inferred rather than observed.$150 Billion Hallucination Problem: Why Expert Data is Silent ↗Hallucination Detection Tools Market Research Report 2033 ↗
Regulatory tailwinds (FDA, EU AI Act on high-risk medical AI) and persistent hallucination concerns support multi-year demand, but the layer risks being absorbed as frontier LLMs ship native uncertainty quantification and self-consistency signals internally.Mitigating hallucinations in healthcare AI: a systematic review ↗Enhancing Clinician Trust in AI Diagnostics ↗
Technically demonstrated by the Consensus Mechanism paper and trust-calibration frameworks, but a clinical wrapper likely requires HIPAA compliance and potential FDA Class II SaMD designation, and validating that an auditor reliably flags 'confidently wrong' cases needs costly clinical studies.Second Opinion Matters: Consensus Mechanism ↗Clinician-informed XAI evaluation checklist CLIX-M ↗